SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-028949
Filing Date
2022-05-23
Accepted
2022-05-23 16:15:35
Documents
14
Period of Report
2022-05-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea160458-8k425_biotech.htm   iXBRL 8-K 62937
2 AMENDMENT TO AGREEMENT AND PLAN OF MERGER, DATED MAY 17, 2022, BETWEEN BIOTECH A ea160458ex2-1_biotechacq.htm EX-2.1 69264
  Complete submission text file 0001213900-22-028949.txt   381739

Data Files

Seq Description Document Type Size
3 XBRL DEFINITION FILE biotu-20220517_def.xml EX-101.DEF 27521
4 XBRL LABEL FILE biotu-20220517_lab.xml EX-101.LAB 37982
5 XBRL PRESENTATION FILE biotu-20220517_pre.xml EX-101.PRE 26139
6 XBRL SCHEMA FILE biotu-20220517.xsd EX-101.SCH 4183
8 EXTRACTED XBRL INSTANCE DOCUMENT ea160458-8k425_biotech_htm.xml XML 7156
Mailing Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001
Business Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001 8586920539
Biotech Acquisition Co (Filer) CIK: 0001825413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39935 | Film No.: 22951772
SIC: 2834 Pharmaceutical Preparations